Obiettivo A large number of implant is available for osseous repair, and fresh autogenous bone grafts are preferred because of their compatibility. However there are several disadvantages associated with the use of autogenous bone, especially due to the limited supply at any one donor site and the added morbidity associated with its harvest (wound problems, permanent sensory loss...). This project aims to develop a new polyurethane polymer as a hard tissue adhesive for fractured bone The new biomaterial will ensure a best security compared with current procedures, as it eliminates the risk of transmission diseases due to foreign bone and the drawbacks linked to multi-chirurgical procedures.The following R&D actions will be carried out:- To examine that the biomaterial comes into contact with tissues and biological fluids- To ensure that the repositioned bone fragments adhered well to their original sites- To develop a controllable degradative process: study of the mode of degradation and excretion of the biomaterial- To promote bone reconstruction (osteoinduction). It will be also necessary to develop a new approach, procedures and surgery technique. Campo scientifico medical and health sciencesclinical medicinesurgerynatural scienceschemical sciencespolymer sciencespolyurethaneengineering and technologyindustrial biotechnologybiomaterials Programma(i) FP5-GROWTH - Programme for research technological development and demonstration on "Competitive and sustainable growth 1998-2002" Argomento(i) 1.1.3.-5. - RTD Activities of a Generic Nature : materials and their technologies for production and transformation and new and improved materials and production technologies in the steel field Invito a presentare proposte Data not available Meccanismo di finanziamento EAW - Exploratory awards Coordinatore CURASAN PHARMA GMBH Contributo UE Nessun dato Indirizzo Lindigstrasse 4 63801 KLEINOSTHEIM Germania Mostra sulla mappa Costo totale Nessun dato Partecipanti (1) Classifica in ordine alfabetico Classifica per Contributo UE Espandi tutto Riduci tutto STATICE SANTE S.A. Francia Contributo UE Nessun dato Indirizzo Rue Thomas Edison 9, Zone Industrielle des Tiller 25000 BESANCON Mostra sulla mappa Costo totale Nessun dato